نتایج جستجو برای: her2 gene

تعداد نتایج: 1152029  

2016
XIAOPING SONG KAILV SUN JIANMING HU JIANGHU ZHOU

The function of human epidermal growth factor receptor 2 (HER2) in the chemosensitivity of ovarian carcinoma has not been fully investigated, therefore, the present study aimed to analyze the potential role of HER2 in ovarian carcinoma chemosensitivity in further detail. SKOV3 cells were transfected with lentiviral-mediated HER2-small hairpin RNA (shRNA) molecules to establish the stable expres...

Journal: :Cancer research 2007
Guilian Niu W Bradford Carter

Abnormal activation of human epidermal growth factor receptor 2 (HER2; ErbB-2) in breast tumors results in increased metastasis and angiogenesis, as well as reduced survival. Here, we show that angiopoietin-2 (Ang-2) expression correlates with HER2 activity in human breast cancer cell lines. Inhibiting HER2 activity with anti-HER2 monoclonal antibody trastuzumab (Herceptin) or HER2 short interf...

2016
Jae-Sung Kim Hyun-Ah Kim Min-Ki Seong Hyesil Seol Jeong Su Oh Eun-Kyu Kim Jong Wook Chang Sang-Gu Hwang Woo Chul Noh

Although radiotherapy resistance is associated with locoregional recurrence and distant metastasis in breast cancers, clinically relevant molecular markers and critical signaling pathways of radioresistant breast cancer are yet to be defined. Herein, we show that HER2-STAT3-survivin regulation is associated with radiotherapy resistance in HER2-positive breast cancers. Depletion of HER2 by siRNA...

Journal: :Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2005
Montse Verdú Artufel Anna Colomer Valero Ruth Román Lladó Nadina Erill Sagalés Miquel Calvo Llorca Abelardo Moreno Carazo Carlos Cordón Cardó Xavier Puig Torrus

BACKGROUND The HER2/neu proto-oncogene is frequently over-expressed in breast cancer and serves as a biological target for trastuzumab therapy. However, there is no consensus regarding the technical aspects to be used to define HER2/neu status in clinical practice. METHODS The present study was conducted to address this critical issue by prospectively analysing a large cohort of breast cancer...

Journal: :Endocrine-related cancer 2005
W F Symmans D J Fiterman S K Anderson M Ayers R Rouzier V Dunmire J Stec V Valero N Sneige C Albarracin Y Wu J S Ross P Wagner R L Theriault B Arun H Kuerer K R Hess W Zhang G N Hortobagyi L Pusztai

The pathogenesis of breast cancers that do not express estrogen receptors or Her-2/neu receptors (ER-/HER2- phenotype) is incompletely understood. We had observed markedly elevated gene expression of gamma-aminobutyric acid type A (GABA(A)) receptor subunit pi (GABApi, GABRP) in some breast cancers with ER-/HER2- phenotype. In this study, transcriptional profiles (TxPs) were obtained from 82 pr...

2011
Zachary C. Hartman Xiao-Yi Yang Oliver Glass Gangjun Lei Takuya Osada Sandeep S. Dave Michael A. Morse Timothy M. Clay Herbert K. Lyerly

HER2 overexpression occurs in approximately 25% of breast cancers, where it correlates with poor prognosis. Likewise, systemic inflammation in breast cancer correlates with poor prognosis, although the process is not understood. In this study, we explored the relationship between HER2 and inflammation, comparing the effects of overexpressing wild-type or mutated inactive forms of HER2 in primar...

2013
Ling Shan Jianming Ying Ning Lu

BACKGROUND With varied immunohistochemistry scoring criteria and patient cohorts, HER2-positivity rates in gastric cancer (GC) and gastroesophageal junction (GEJ) adenocarcinoma have been reported with a wide range. Recently standardized scoring criteria for GC and GEJ cancer has been established and recommended. In this study, the frequency of HER2 expression and the relationship between HER2 ...

Journal: :Hematology/oncology clinics of North America 2007
Gustavo Ismael Daniela Dornelles Rosa Evandro de Azambuja Sofia Braga Martine Piccart-Gebhart

Breast cancer patients who have HER2 gene amplification and, consequently, protein overexpression, generally show an aggressive course with short disease-free and overall survivals. Trastuzumab, a humanized monoclonal antibody against the extracellular domain of HER2 protein, has been shown to benefit patients who have HER2-positive metastatic breast cancer, and recently, the results of five ad...

2015
Yeon Hee Park Hyun-Tae Shin Hae Hyun Jung Yoon-La Choi TaeJin Ahn Kyunghee Park Aeri Lee In-Gu Do Ji-Yeon Kim Jin Seok Ahn Woong-Yang Park Young-Hyuck Im

In women with metastatic breast cancer (MBC), introduction of the anti-HER2 (human epidermal growth factor receptor-2) directed therapies including trastuzumab, pertuzumab, lapatinib, and/or trastuzumab-DM1 has markedly improved overall survival. However, not all cases of HER2-positive breast tumours derive similar benefit from HER2-directed therapy, and a significant number of patients experie...

Journal: :Oncology reports 2010
Sheng Cao Yang Li Jin Li Chang-Fei Li Wei Zhang Zeng-Qi Yang Song-Dong Meng

HER2 analysis in circulating tumor cells (CTCs) may have clinical significance for HER2-targeted therapy as HER2-positive CTCs and disseminated tumor cells can be detected in patients with HER2-negative primary tumors who currently do not have access to HER2-targeted therapy. In this study, we performed quantitative analysis by confocal microscopy assay for evaluation of HER2 expression in indi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید